Skip to main content
OpenTrials
Completed

NCT Number: NCT04461106

A New Measure of Egg Consumption and the Effect of Social Marketing Eggs

About 1600 children 6 to 24 months old will be enrolled from 8 egg hubs. 4 hubs will be receive social marketing campaign to raise awareness about the benefits of eggs while the other 4 will not receive social marketing campaign. Children will provide a urine sample for analysis of metabolites to correlate with egg consumption.

Completed

Looking for future studies?

Notify Me

Key information

Age range

6 month–24 month

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Project Peanut Butter

Blantyre, Malawi

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Health children between 6 and 24 months of age

Exclusion criteria

  • acute malnutrition
  • congenital abnormalities
  • chronic debilitation disease such as heart disease, cerebral palsy, or HIV infection

Treatment and study plan

Social marketing campaign

Other

aims to raise awareness about the benefits of eggs - 'why eggs': increasing the value of eggs from a consumer perspective and encourage consumption of eggs by children (<5yrs) and pregnant/lactating women

Primary outcomes

  1. Amount of egg consumed daily

    Time frame: 12 Months

    As determined by urinary metabolite concentrations. The specific metabolites will be identified in the course of the study.

Sponsors and collaborators

Lead sponsor

Washington University School of Medicine

Other

Collaborators

  • Kamuzu University of Health Sciences
  • Project Peanut Butter, Malawi

Registry information

Official study title

A Two-Phase Study to Investigate Novel Biomarkers of Egg Consumption and Social Marketing Effectiveness of Egg Hubs for Malawian Infants

Important dates

Study start
2021
Primary completion
2021
Study completion
2022
First posted
Jul 8, 2020
Registry last updated
Feb 27, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.